3M Wins Frost and Sullivan Award

3M Health Care’s performance in the wound care market segment has earned them the 2006 Wound Care Practitioner Choice Customer Service Leadership Award from Frost & Sullivan. Frost & Sullivan is a global growth consulting company with a knack for keeping an eagle eye on the industry. According to F&S…

“3M Health Care has shown tremendous responsiveness to customer needs and has continually focused on leading the industry in key areas, including most frequently used and most preferred brand metrics,” said Sheila Ewing, research analyst, Frost & Sullivan. “Through its demonstration of creating products with an exceptional level of performance and reliability, we believe 3M Health Care is well-positioned to continue leading the U.S. wound care market, and we are pleased to honor 3M with our Customer Service Leadership Award.”
To select the recipient of this Award, Frost & Sullivan surveyed 150 wound care practitioners in the United States who actively use wound care products. Survey participants indicated which company they considered the best for each category listed, and Awards were selected based upon the company receiving the highest ranking. Survey results indicated wound care practitioners view 3M Health Care as a preferred brand of wound care products and services. The survey showed that customers value 3M Health Care’s products due to their ease of use and high level of comfort for the patient. Survey respondents also selected 3M as the best provider of training for new products.
In addition to receiving one of the highest overall satisfaction rates for its products, 3M was selected by wound care practitioners as the leader in the following categories:
— Most frequently used brand for staples and adhesive skin closures
— Most preferred brand for staples, adhesive skin closures, active dressings and tissue engineering

Way to go 3M Healthcare! Now, go ahead and take the rest of the week off. Does anyone out there regularly use 3M wound care products? Found this to be the case? We’d be interested to hear if the Medgadget audience shares the F&S opinion.
More from the press release.